Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2000. Start Trial.
Date Value
November 13, 2026 6.805M
November 12, 2026 6.853M
November 11, 2026 7.371M
November 10, 2026 7.681M
November 09, 2026 8.382M
November 06, 2026 8.145M
November 05, 2026 8.490M
November 04, 2026 8.532M
November 03, 2026 8.488M
November 02, 2026 8.302M
October 30, 2026 8.550M
October 29, 2026 8.072M
October 28, 2026 8.054M
October 27, 2026 8.340M
October 26, 2026 10.54M
October 23, 2026 10.57M
October 22, 2026 10.66M
October 21, 2026 10.29M
October 20, 2026 9.140M
October 19, 2026 9.016M
October 16, 2026 9.233M
October 15, 2026 9.482M
October 14, 2026 9.358M
October 13, 2026 9.544M
October 12, 2026 9.544M
Date Value
October 09, 2026 9.606M
October 08, 2026 9.544M
October 07, 2026 9.979M
October 06, 2026 9.854M
October 05, 2026 10.60M
October 02, 2026 10.85M
October 01, 2026 11.10M
September 30, 2026 10.91M
September 29, 2026 7.210M
September 28, 2026 7.420M
September 25, 2026 7.560M
September 24, 2026 7.280M
September 23, 2026 7.840M
September 22, 2026 8.026M
September 21, 2026 7.653M
September 18, 2026 7.326M
September 17, 2026 7.420M
September 16, 2026 7.560M
September 15, 2026 7.513M
September 14, 2026 7.816M
September 11, 2026 7.840M
September 10, 2026 7.746M
September 09, 2026 8.026M
September 08, 2026 8.166M
September 04, 2026 8.353M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Altimmune, Inc. 91.12M
Taysha Gene Therapies, Inc. 967.94M
Agenus, Inc. 487.93M
Amgen, Inc. 292.70B
Anika Therapeutics, Inc. 160.67M

Enterprise Value Related Metrics